Log In Get Started
Stock Markets July 8, 2026 08:59 AM

AeroVironment Lifts Guidance, Eyes Doubling Revenue by 2030; Shares Jump on Investor-Day Slides

Defense tech firm projects sustained organic growth and margin expansion through fiscal 2030 while increasing R&D investment

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
AVAV

AeroVironment shares climbed 7% after the company released slides ahead of its investor day outlining financial targets through fiscal 2030, including 15%–20% organic revenue growth, adjusted EBITDA margins of 18%–20%, and a plan to raise R&D to 7%–9% of revenue beginning in fiscal 2027. The firm also gave fiscal 2027 guidance and reiterated a goal to roughly double revenue by 2030 via organic growth and market expansion.

AeroVironment Lifts Guidance, Eyes Doubling Revenue by 2030; Shares Jump on Investor-Day Slides
AVAV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • AeroVironment unveiled fiscal 2030 targets of 15%–20% organic revenue growth and adjusted EBITDA margins of 18%–20%, implying a 350–550 basis-point margin expansion.
  • Fiscal 2027 guidance: $2.125 billion to $2.225 billion in revenue (about 10% YoY growth at the midpoint) and adjusted EBITDA of $305 million to $325 million (14.5% margin at midpoint).
  • The company will raise R&D to 7%–9% of revenue in fiscal 2027, up from 6% in fiscal 2026, and maintain that level through fiscal 2030; strategic priorities emphasize innovation, operational execution, and profitable growth. (Impacted sectors: defense, aerospace, technology, and equity markets)

Shares of AeroVironment (NASDAQ:AVAV) rose 7% Wednesday morning after the company posted presentation slides in advance of its investor day detailing multi-year financial targets and near-term guidance.

Longer-term targets

The defense technology firm set out a target range for fiscal 2030 that calls for organic revenue growth of 15% to 20% and adjusted EBITDA margins of 18% to 20%. The company said that those margin targets represent an improvement of 350 to 550 basis points versus current levels.

Fiscal 2027 outlook

For fiscal 2027, AeroVironment gave a revenue guide of $2.125 billion to $2.225 billion, which the company said equates to roughly 10% year-over-year growth at the midpoint compared with fiscal 2026 revenue of about $2.0 billion. Adjusted EBITDA for fiscal 2027 was projected between $305 million and $325 million, which corresponds to a 14.5% margin at the midpoint.

Investment and strategy

The presentation indicated the company will increase research and development spending to a range of 7% to 9% of revenue in fiscal 2027, up from 6% in fiscal 2026, and pledged to keep that higher investment level through fiscal 2030. Management identified strategic priorities centered on innovation to drive revenue, operational execution to improve performance, and seizing opportunities to boost profitability. The company characterized its approach as a disciplined growth strategy aimed at sustainable margin expansion alongside faster organic revenue growth.

Corporate objective

AeroVironment stated a long-term objective to approximately double revenue by 2030 through organic growth fueled by innovation and market expansion. The company also reported that its fiscal 2026 adjusted EBITDA margin stood at 14.5%.

Market reaction

The investor-day materials and forward-looking financial targets corresponded with a positive market reaction, with the stock trading higher in the morning following the slide release.

All figures and targets in this report are drawn directly from the company’s presentation slides made available ahead of its investor day.

Risks

  • Achieving the targeted 18%–20% adjusted EBITDA margin by fiscal 2030 while increasing R&D spending to 7%–9% of revenue presents execution and profitability risk for the defense technology sector.
  • Meeting the company’s objective to approximately double revenue by 2030 relies on successful organic growth and market expansion, which may be uncertain and affects defense and aerospace market outlooks.
  • Near-term guidance assumes maintaining a 14.5% adjusted EBITDA margin at the fiscal 2027 midpoint; failure to reach that margin would present downside risk to investor expectations and equity performance.

More from Stock Markets

Definium Therapeutics Shares Rise After Stifel Doubles Price Target on Strong Phase 3 MDD Data Jul 8, 2026 OpenAI Deployment Unit to Buy Northslope to Expand Enterprise AI Services Jul 8, 2026 AMD Inches Higher After Sharp Drop as Analysts and Competitive Dynamics Shape Near-Term Outlook Jul 8, 2026 U.S. to License Local Production of Patriot Interceptors for Ukraine, Trump Says Jul 8, 2026 Supermicro Shares Climb After Launch of Turnkey Kubernetes Edge AI Appliance Jul 8, 2026